GALLERANI, Eleonora
 Distribuzione geografica
Continente #
NA - Nord America 2.111
EU - Europa 927
AS - Asia 347
AF - Africa 5
SA - Sud America 1
Totale 3.391
Nazione #
US - Stati Uniti d'America 2.109
PL - Polonia 342
IT - Italia 262
CN - Cina 181
UA - Ucraina 85
TR - Turchia 72
DE - Germania 62
GB - Regno Unito 62
SG - Singapore 45
SE - Svezia 36
BE - Belgio 30
FI - Finlandia 20
VN - Vietnam 17
ID - Indonesia 14
IR - Iran 10
FR - Francia 8
CZ - Repubblica Ceca 5
DZ - Algeria 5
NL - Olanda 3
RO - Romania 3
AT - Austria 2
CA - Canada 2
HK - Hong Kong 2
IE - Irlanda 2
IN - India 2
KR - Corea 2
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
IL - Israele 1
MN - Mongolia 1
NO - Norvegia 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 3.391
Città #
Warsaw 342
Fairfield 254
Woodbridge 228
Ann Arbor 210
Houston 188
Chandler 176
Ferrara 168
Ashburn 141
Jacksonville 114
Seattle 108
Cambridge 107
Wilmington 103
Beijing 44
Izmir 38
New York 33
Shanghai 33
Nanjing 31
Princeton 31
San Diego 31
Brussels 30
Singapore 23
Boardman 21
Milan 19
Bologna 17
Dong Ket 17
Jakarta 14
Shenyang 12
Hebei 9
Nanchang 9
Dearborn 8
Augusta 7
Changsha 7
Des Moines 6
Ferrara di Monte Baldo 6
Jiaxing 6
Leawood 6
Los Angeles 6
Mountain View 6
Redwood City 6
Washington 6
Ardabil 5
Bremen 5
Brno 5
Jinan 5
Modena 5
Norwalk 5
Rome 5
Addison 4
Indiana 4
London 4
Ningbo 4
Sharif 4
Amsterdam 3
Auburn Hills 3
Falls Church 3
Kunming 3
Munich 3
Orange 3
Portsmouth 3
San Mateo 3
Tianjin 3
Dublin 2
Frankfurt am Main 2
Haikou 2
Hangzhou 2
Hong Kong 2
Massapequa 2
New Bedfont 2
Phoenix 2
Redmond 2
San Francisco 2
Seoul 2
Taizhou 2
Tappahannock 2
Vienna 2
Acton 1
Aprilia 1
Bari 1
Beirã 1
Bengaluru 1
Borgo Valsugana 1
Bretagne 1
Bucharest 1
Canonsburg 1
Changchun 1
Chiswick 1
Duluth 1
Edinburgh 1
Falkenstein 1
Farmville 1
Fort Collins 1
Fuzhou 1
Grassano 1
Guangzhou 1
Hefei 1
Iasi 1
Islington 1
Jerusalem 1
Kilburn 1
Kish 1
Totale 2.756
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 256
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 244
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 192
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 162
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 149
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 148
NO Photoreleaser-Deoxyadenosine and -Bile Acid Derivative Bioconjugates as Novel Potential Photochemotherapeutics 147
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 138
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 137
Nafion®-containing solid lipid nanoparticles as a tool for anticancer pt delivery: preliminary studies 132
Incorporation of Naked Peptide Nucleic Acids into Liposomes Leads to Fast and Efficient Delivery 131
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 127
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 126
Rational design of nucleoside-bile acid conjugates incorporating a triazole moiety for anticancer evaluation and SAR exploration 125
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 120
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (ii) carboxylates 117
Synthesis, characterization and antiproliferative activity of amino- and DMSO complexes of platinum(II) containing L-carnitine 113
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 112
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 105
Comparative antiproliferative activities of wood and seeds essential oils of Juniperus oxycedrus L. against K562 human chronic myelogenus leukemia cells. 95
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 91
Encapsulation of dedifferentiated nasal septal chondrocytes in alginate based scaffolds for cartilage tissue engineering 85
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 75
null 49
Hpv-specific systemic antibody responses and memory b cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with cervarix and gardasil in adolescent and young adult women in vaccination programs in Italy 44
null 43
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 41
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 37
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 35
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans 35
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 24
Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2 23
HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors 16
Design, Synthesis and Evaluation of New Multifunctional Benzothiazoles as Photoprotective, Antioxidant and Antiproliferative Agents 13
ANTIRETROVIRAL THERAPY PARTIALLY RESTORES PHENOTYPIC AND METABOLIC IMMUNOSENESCENCE FEATURES OF T CELLS IN HIV INFECTED INDIVIDUALS 10
Totale 3.497
Categoria #
all - tutte 14.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.132


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020736 106 35 31 102 61 75 65 63 68 66 38 26
2020/2021701 52 32 24 43 56 50 34 89 39 149 84 49
2021/2022378 18 43 10 22 9 15 41 23 25 34 30 108
2022/2023417 41 31 22 59 54 46 35 45 48 2 23 11
2023/2024277 36 38 10 11 14 57 18 16 3 5 11 58
2024/202523 23 0 0 0 0 0 0 0 0 0 0 0
Totale 3.497